Discontinuation report URSO DS
| Report ID | 177864 |
| Drug Identification Number | 02245894 |
| Brand name | URSO DS |
| Common or Proper name | Urso ( ursodiol) tablets |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | URSODIOL |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100s |
| ATC code | A05AA |
| ATC description | BILE THERAPY |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-04-01 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-12-10 | French | Compare |
| v1 | 2022-12-10 | English | Compare |
Showing 1 to 2 of 2